Porsolt, a French contract drug researcher, bought a company focused on discovery-stage services. Acquiring the Bordeaux-headquartered Fluofarma, Porsolt is adding more capacity in cell-based assays, in vitro screening and other technology to pad its existing offerings in preclinical development. Release
> The FDA met its deadline of launching precisionFDA before year's end, unveiling its new informatics platform. News
> Indian drugmaker Sun Pharma is reportedly looking to buy local rival Intas Pharmaceuticals for $2.3 billion. Story